RU2014145931A - Композиция для лечения нарушений метаболизма - Google Patents

Композиция для лечения нарушений метаболизма Download PDF

Info

Publication number
RU2014145931A
RU2014145931A RU2014145931A RU2014145931A RU2014145931A RU 2014145931 A RU2014145931 A RU 2014145931A RU 2014145931 A RU2014145931 A RU 2014145931A RU 2014145931 A RU2014145931 A RU 2014145931A RU 2014145931 A RU2014145931 A RU 2014145931A
Authority
RU
Russia
Prior art keywords
composition
composition according
extract
plant
terminalia elliptica
Prior art date
Application number
RU2014145931A
Other languages
English (en)
Russian (ru)
Inventor
Арвинд САКЛАНИ
Нилеш МАЛПУРЕ
Парикшит ГАЙКВАД
Сатиш Намдео САВАНТ
Тукарам Кисанрао МАНЕ
Сомеш ШАРМА
Original Assignee
Пирамал Энтерпрайзис Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пирамал Энтерпрайзис Лимитед filed Critical Пирамал Энтерпрайзис Лимитед
Publication of RU2014145931A publication Critical patent/RU2014145931A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
RU2014145931A 2012-04-23 2013-04-22 Композиция для лечения нарушений метаболизма RU2014145931A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261636792P 2012-04-23 2012-04-23
US61/636,792 2012-04-23
PCT/IB2013/053155 WO2013160811A1 (en) 2012-04-23 2013-04-22 Composition for treating metabolic disorders

Publications (1)

Publication Number Publication Date
RU2014145931A true RU2014145931A (ru) 2016-06-20

Family

ID=49482298

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014145931A RU2014145931A (ru) 2012-04-23 2013-04-22 Композиция для лечения нарушений метаболизма

Country Status (16)

Country Link
US (1) US20150290265A1 (enExample)
EP (1) EP2841080A4 (enExample)
JP (1) JP2015514797A (enExample)
KR (1) KR20150003862A (enExample)
CN (1) CN104244962A (enExample)
AU (1) AU2013254329A1 (enExample)
BR (1) BR112014026326A2 (enExample)
CA (1) CA2870907A1 (enExample)
IL (1) IL235317A0 (enExample)
IN (1) IN2014MN02269A (enExample)
MX (1) MX2014012742A (enExample)
NZ (1) NZ701133A (enExample)
RU (1) RU2014145931A (enExample)
SA (1) SA113340494B1 (enExample)
TW (1) TW201343174A (enExample)
WO (1) WO2013160811A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3233188A4 (en) * 2014-12-19 2018-11-07 Halo Life Science, LLC Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels
EP3529245A4 (en) 2016-10-24 2020-12-23 Yumanity Therapeutics, Inc. COMPOUNDS AND USES OF THE LATEST
MA47212A (fr) 2017-01-06 2019-11-13 Yumanity Therapeutics Inc Méthodes de traitement de troubles neurologiques
WO2019084157A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. COMPOUNDS AND USES THEREOF
MX2020007394A (es) 2018-01-10 2020-09-03 Brightseed Inc Metodo para modular el metabolismo.
ES3043183T3 (en) 2018-03-23 2025-11-25 Janssen Pharmaceutica Nv Compounds and uses thereof
MA54829A (fr) 2019-01-24 2021-12-01 Yumanity Therapeutics Inc Composés et leurs utilisations
KR20220100896A (ko) 2019-11-11 2022-07-18 브라이트씨드, 인크. 추출물, 소모가능 생성물 및 추출물에서 생물활성 대사산물을 농후화하는 방법
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение
KR102408566B1 (ko) * 2020-04-09 2022-06-16 대한민국 터미날리아 비아라타 추출물을 이용한 피부 주름 개선용 조성물
JP2023144436A (ja) * 2022-03-28 2023-10-11 住友化学株式会社 エラグ酸含有組成物の製造方法及びエラグ酸含有組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005053864A (ja) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk 糖尿病疾患予防・治療剤
JP2006188486A (ja) * 2004-12-07 2006-07-20 Toyo Shinyaku:Kk 体脂肪蓄積抑制または低減剤
AP2007004162A0 (en) * 2005-02-23 2007-10-31 Avestha Gengraine Tech Pvt Ltd Plant extracts and methods and uses therefore

Also Published As

Publication number Publication date
IN2014MN02269A (enExample) 2015-07-24
MX2014012742A (es) 2015-04-08
US20150290265A1 (en) 2015-10-15
SA113340494B1 (ar) 2015-12-24
EP2841080A4 (en) 2015-11-25
BR112014026326A2 (pt) 2017-06-27
NZ701133A (en) 2016-08-26
TW201343174A (zh) 2013-11-01
AU2013254329A1 (en) 2014-11-13
IL235317A0 (en) 2014-12-31
CA2870907A1 (en) 2013-10-31
EP2841080A1 (en) 2015-03-04
WO2013160811A1 (en) 2013-10-31
KR20150003862A (ko) 2015-01-09
JP2015514797A (ja) 2015-05-21
CN104244962A (zh) 2014-12-24

Similar Documents

Publication Publication Date Title
JP2015514797A5 (enExample)
RU2471782C2 (ru) Твердые формы, содержащие (+)-2-[1-(3-этокси-4-метоксифенил)-2-метилсульфонилэтил]-4-ацетиламиноизоиндолин-1, 3-дион, их композиции и применение
JP2014533680A5 (enExample)
ES2752039T3 (es) Agente terapéutico para la dislipidemia
JP2022180461A5 (enExample)
RU2020123679A (ru) Композиции и способы лечения и/или предотвращения сердечно-сосудистого заболевания
WO2009008006A3 (en) Pharmaceutical compositions for gastrointestinal drug delivery
JP2012520343A5 (enExample)
IL314360A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
WO2010092450A8 (en) Stable pharmaceutical composition for atherosclerosis
JP2009539994A5 (enExample)
JP2013536837A5 (enExample)
CN110898025A (zh) 阿卡波糖缓释制剂及其制备方法
WO2012042197A3 (en) Low dose pharmaceutical composition comprising zanamivir
RU2014140852A (ru) Растительная композиция для лечения нарушений обмена веществ
EA021395B1 (ru) Комбинация инсулина с триазиновыми производными и их применение для лечения диабета
JP2023530500A5 (enExample)
RU2012131959A (ru) Способ лечения остеоартрита
JP6761346B2 (ja) 脂質異常症治療剤
US20200246314A1 (en) Dyslipidemia therapeutic agent
RU2011129815A (ru) Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи
CN103919776B (zh) 一种治疗关节炎的药物组合物
RU2023125283A (ru) Фармацевтические композиции, содержащие флурбипрофен
RU2338531C1 (ru) Активные субстанции, фармацевтическая композиция, способ получения и применения
KR20130036990A (ko) 통증완화의 효과가 있는 약학적 조성물